NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today it has initiated preclinical animal testing of the first construct of its HaloVax Self-Assembling Vaccine (SAV) ...
NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today the successful completion of its previously announced first small animal safety and immunogenicity study ...
Scientists have developed a new way to track neural activity. The technique can target specific brain cells and relies on dyes that are brighter and more stable than those currently used. Luke Lavis ...
NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced positive data from its second set of preclinical animal testing of its HaloVax™ Self-Assembling Vaccine (SAV) ...
Luke Lavis has spent years developing fluorescent dyes in every color of the rainbow. The super-bright, long-lasting dyes have been used in labs around the world and have helped make Nobel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback